A first consignment of 37,920 doses of the groundbreaking, six-monthly HIV prevention injection, Lenacapavir, has arrived in South Africa last week, the National Department of Health announced on Tuesday.
The department described the arrival of the medicine, provided through a 29-million-U.S.-dollar grant from the Global Fund, as a vital reinforcement for the country, which manages the world’s largest HIV-positive population of approximately 8 million people, with over 6 million currently on antiretroviral treatment.
South Africa receives 1st shipment of HIV prevention medicine Lenacapavir
Categories: